Link to this page
SNOMED CT, US Edition
| Id | http://purl.bioontology.org/ontology/SNOMEDCT/1260180004
http://purl.bioontology.org/ontology/SNOMEDCT/1260180004
|
|---|---|
| Preferred Name | Growing teratoma syndrome |
| Definitions |
A rare neoplastic disorder characterized by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumors of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumor markers have normalized. The retroperitoneum is the most common site, although almost any other localization has been reported. Increased tumor size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischemia and biliary obstruction as major complications.
A rare neoplastic disorder characterised by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumours of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumour markers have normalised. The retroperitoneum is the most common site, although almost any other localisation has been reported. Increased tumour size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischaemia, and biliary obstruction as major complications.
A rare neoplastic disorder characterised by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumours of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumour markers have normalised. The retroperitoneum is the most common site, although almost any other localisation has been reported. Increased tumour size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischaemia and biliary obstruction as major complications.
A rare neoplastic disorder characterized by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumors of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumor markers have normalized. The retroperitoneum is the most common site, although almost any other localization has been reported. Increased tumor size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischemia, and biliary obstruction as major complications.
|
| Synonyms |
Growing teratoma syndrome (disorder)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A rare neoplastic disorder characterized by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumors of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumor markers have normalized. The retroperitoneum is the most common site, although almost any other localization has been reported. Increased tumor size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischemia and biliary obstruction as major complications. A rare neoplastic disorder characterised by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumours of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumour markers have normalised. The retroperitoneum is the most common site, although almost any other localisation has been reported. Increased tumour size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischaemia, and biliary obstruction as major complications. A rare neoplastic disorder characterised by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumours of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumour markers have normalised. The retroperitoneum is the most common site, although almost any other localisation has been reported. Increased tumour size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischaemia and biliary obstruction as major complications. A rare neoplastic disorder characterized by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumors of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumor markers have normalized. The retroperitoneum is the most common site, although almost any other localization has been reported. Increased tumor size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischemia, and biliary obstruction as major complications. |
|---|---|
| prefLabel | Growing teratoma syndrome
|
| altLabel | Growing teratoma syndrome (disorder)
|
| Type ID |
900000000000003001
900000000000013009
|
| Semantic type UMLS property | |
| Occurs after | |
| Effective time | 20230131
|
| cui | C3891714
|
| CTV3ID | XVK3A
|
| DEFINITION STATUS ID | 900000000000074008
|
| CASE SIGNIFICANCE ID | 900000000000448009
|
| tui | T191
|
| Active | 1
|
| Has associated morphology | |
| notation | 1260180004
|
| type | |
| subClassOf | |
| Subset member | 447562003~MAPRULE~TRUE
6011000124106~MAPGROUP~1
6011000124106~MAPGROUP~2
6011000124106~MAPTARGET~D36.9
447562003~MAPGROUP~1
447562003~CORRELATIONID~447561005
6011000124106~MAPCATEGORYID~447637006
6011000124106~MAPTARGET~T45.1X5?
900000000000509007~ACCEPTABILITYID~900000000000548007
6011000124106~MAPADVICE~ALWAYS D36.9
900000000000508004~ACCEPTABILITYID~900000000000548007
447562003~MAPPRIORITY~1
447562003~MAPCATEGORYID~447637006
447562003~MAPTARGET~D36.9
6011000124106~MAPPRIORITY~1
6011000124106~CORRELATIONID~447561005
6011000124106~MAPRULE~TRUE
900000000000497000~MAPTARGET~XVK3A
6011000124106~MAPADVICE~ALWAYS T45.1X5? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED
447562003~MAPADVICE~ALWAYS D36.9 | MAPPED FOLLOWING SNOMED GUIDANCE | POSSIBLE REQUIREMENT FOR MORPHOLOGY CODE
See more
See less
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |